Search clinical trials for: innohep®

Total 13682 results

Assistance Publique - Hôpitaux de Paris
LEO Pharma

Completed

Therapeutic Anticoagulation Strategy for Acute Chest Syndrome (TASC)

Anemia | Acute Chest Syndrome | Sickle Cell | Low-Molecular-Weight Heparin

France
LEO Pharma

Completed

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Deep Vein Thrombosis

Bulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
University of Aarhus
Aarhus University Hospital; LEO Pharma

Completed

Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight? (IUGR)

Fetal Growth Retardation

Denmark
LEO Pharma

Completed

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE) (PREDICARE)

Venous Thromboembolism

France
University Hospital, Linkoeping
Vastra Gotaland Region; Region Jönköping County; Region Västerbotten; Västervik...

Recruiting

Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian Cancer

Epithelial Ovarian Cancer

Sweden
Cardiff University
National Institute for Health Research, United Kingdom; Wales Cancer Trials...

Terminated

Anticoagulation Length in Cancer Associated Thrombosis (ALICAT)

Cancer | Thrombosis | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United Kingdom
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
LEO Pharma

Completed

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

Venous Thromboembolism

Canada
Duke University
Celgene Corporation

Completed

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Primary Brain Tumor

United States
King Saud University
King AbdulAziz City for Science and Technology

Unknown

Venous Thromboembolism Prophylaxis Post Cesarean Section (PROCS)

Bleeding | Venous Thromboembolism

Saudi Arabia
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
St. Joseph's Healthcare Hamilton
LEO Pharma; Heart and Stroke Foundation of Ontario

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
Central Finland Hospital District

Completed

BEMER in the Treatment of Pain in Fibromyalgia. (Fibromyalgia)

Fibromyalgia

Finland
University Hospital of Patras

Recruiting

Intensive Dose Tinzaparin in Hospitalized COVID-19 Patients (INTERACT)

Covid19 | Hospitalization

Greece
Ottawa Hospital Research Institute
LEO Pharma

Completed

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Hemodialysis | Thromboembolism

Canada
Ottawa Hospital Research Institute

Recruiting

STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated Thrombosis

Thrombocytopenia | Cancer-associated Thrombosis

Canada
Karolinska Institutet

Completed

Dosing of Thromboprophylaxis and Mortality in Critically Ill COVID-19 Patients

Covid19 | Thromboembolism

Sweden
Hospital Universitari de Bellvitge
LEO Pharma

Completed

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Venous Thromboembolism

Spain
Christine Ribic
McMaster University; LEO Pharma

Completed

Use of Tinzaparin for Anticoagulation in Hemodialysis (HEMO-TIN)

Kidney Failure, Chronic

Canada
Dong-A ST Co., Ltd.

Completed

A Study to Demonstrate the Efficacy and Safety of Motilitone®

Functional Dyspepsia

Korea, Republic of
Chong Kun Dang Pharmaceutical

Completed

CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers

Healthy

Korea, Republic of
Galderma R&D

Completed

Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis

Atopic Dermatitis

Philippines, China
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immune Response of Different Pediatric Combination Vaccines.

Pertussis | Diphtheria | Polio

United States
Chung-Ang University Hosptial, Chung-Ang University...

Unknown

A Study to Evaluate the Efficacy Between Helicobacter Pylori Eradication Therapy and Motilitone in Functional Dyspepsia

Functional Dyspepsia

Korea, Republic of
Amir Azarpazhooh
Institut Straumann AG

Completed

Effect of Emdogain® on Soft Tissue Wound Healing

Periodontal Inflammation | Crown Lengthening

Canada
Novartis Pharmaceuticals

Completed

Inspiratory Flow Rates Achieved by the COPD Patients Through Breezhaler®, Ellipta® and Handihaler® Inhaler Devices

Pulmonary Disease, Chronic Obstructive (COPD)

Argentina
Guerbet

Completed

Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors (REMIND)

Primary Brain Tumor

Colombia, Korea, Republic of, United States, Mexico
University of Miami
BSN Medical Inc

Recruiting

VLU Dressing Study

Venous Leg Ulcer

United States
Sanofi Pasteur, a Sanofi Company

Completed

Rates of Pertussis Disease Among Persons Receiving Pentacel® or Other Pertussis Vaccines

Pertussis

United States
Coopervision, Inc.

Completed

Clinical Evaluation of Biofinity Multifocal Compared With Air Optix Aqua Multifocal and With PureVision Multifocal (INNOVATION)

Presbyopia
Tufts University

Completed

Comparison of Post Tooth Extraction Healing Using Different Xenograft Materials

Alveolar Bone Loss

United States
Assistance Publique Hopitaux De Marseille

Completed

Clinical Evaluation of the Treatment of Intellectual Metastases by Radiosurgery Gamma Knife by Means of a Support System by Mask. (Mask)

Lung Cancer | Brain Metastases

France
Woman's Health University Hospital, Egypt

Unknown

Preconceptional Thromboprophylaxis in Recurrent PREGNANCY LOSSES Caused by Antiphospholipid Syndrome

Recurrent Pregnancy Losses | Positive Anti Phospholipid Syndrome

Egypt
University Hospital, Caen

Completed

Incidence of Dual Mobility Polyethylene Wear in Total Hip Prosthesis. Randomised Study Versus Fixed Insert by Radiostereometric Analysis. (DOUMOB)

Total Hip Replacement
Global Kinetics Corporation

Withdrawn

Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG (TARGET-PwP)

Parkinson Disease
Chiesi Farmaceutici S.p.A.

Completed

Pharmacokinetic Study of Bramitob® Administered for Inhalation by PARI eFlow® vs PARI LC® PLUS Nebulizer

Cystic Fibrosis

Czechia, Moldova, Republic of, Slovakia
Hoffmann-La Roche

Completed

A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs)

Chronic Renal Anemia

Belgium, Brazil, United Kingdom, Serbia, Spain, Germany, Korea, Republic of, Turkey, Lithuania, Italy, Czechia, Argentina, Australia, Croatia, France, Greece, Israel, Malaysia, Mexico, Panama, Philippines, Poland, Russian Federation, ... and more
Global Kinetics Corporation

Terminated

Utilization of Target Ranges to Treat Parkinson's Disease With the PKG (TARGET-PD)

Parkinson Disease

United States
nthalmic Pty Ltd
Brighten Optix Corporation

Recruiting

S.T.O.P.® Technology Contact Lenses Versus Dual-focus Contact Lenses for Slowing Down Myopia Progression in Children

Myopia

India, Spain, China
Lument AB

Terminated

A Randomized, Controlled Trial to Evaluate CT Image Quality Lumentin® 44

Subjects Referred to CT-examination of the Abdomen

Sweden
Almirall, S.A.
Forest Laboratories

Completed

Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

Chronic Obstructive Pulmonary Disease (COPD)

Germany, Spain, United Kingdom
W.L.Gore & Associates

Active, not recruiting

GORE® TAG® Thoracic Endoprosthesis French Mandatory Registry

Aortic Diseases | Aortic Aneurysm, Thoracic | Penetrating Ulcer | Descending Thoracic Aortic Dissection | Aorta Thoracic; Traumatic Rupture

France
Revance Therapeutics, Inc.

Active, not recruiting

Teosyal RHA® Histology and Intradermal Implantation Evaluation Study

Histology

Canada
Tufts University

Completed

Effect of Mucograft® Seal on Post-extraction Ridge Preservation Using Bone Allograft (Mucograft)

Tooth Extraction Status Nos
CereVasc Inc
AlvaMed, Inc.; Simplified Clinical Data Systems, LLC; Bioscience Consulting,...

Terminated

Pilot Study to Evaluate the CereVasc® eShunt® System in the Treatment of Communicating Hydrocephalus

Hydrocephalus | Hydrocephalus, Communicating

United States
University of Baghdad

Completed

Evaluating Implant Stability Using Three Devices Osstell®, Periotest® and AnyCheck®

Edentulous Alveolar Ridge

Iraq
Novo Nordisk A/S

Completed

A Trial to Investigate the Bioequivalence of Norditropin® (Somatropin) Versus Genotropin® (Somatropin) in Healthy Adult Subjects

Healthy | Growth Disorder

United States

Search clinical trials for: innohep®

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Portugal

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations